Aeolus Pharmaceuticl (AOLS)

Currency in USD
0.0001
0.0000(0.00%)
Closed·

AOLS Financial Summary

Key Ratios

P/E Ratio-0
Price/Book0.07
Debt / Equity0%
Return on Equity-186.43%
Dividend Yield0.00%
EBITDA0.00
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2007
30/09
2008
30/09
2009
30/09
2010
30/09
2011
30/09
2012
30/09
2013
30/09
2014
30/09
2015
30/09
2016
30/09
* In Millions of USD (except for per share items)

Earnings

Latest Release
Feb 17, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
13.00K / --
EPS Revisions
Last 90 days

FAQ

What were Aeolus Pharmaceuticl's earnings for the latest quarter?

The Aeolus Pharmaceuticl EPS (TTM) is -0.03. Aeolus Pharmaceuticl reported sales of 0.01, net income of -0.95, and EPS of -0.01 for the latest quarter.

What was Aeolus Pharmaceuticl's net income for the latest quarter?

Aeolus Pharmaceuticl's net income for the latest quarter was -0.95.

How did Aeolus Pharmaceuticl's performance compare year-over-year in the latest quarter?

The company's revenue moved from 0.13 in the previous quarter to 0.01 in the latest quarter, and net income moved from -1.04 to -0.95 compared to the previous quarter.

What is Aeolus Pharmaceuticl's net profit margin on a TTM basis?

Aeolus Pharmaceuticl's trailing twelve months (TTM) net profit margin is -171.39%.

How does Aeolus Pharmaceuticl's debt to equity ratio compare to industry standards?

Aeolus Pharmaceuticl's total debt-to-equity ratio is 0.00%.

What is Aeolus Pharmaceuticl's return on investment on a TTM basis?

Aeolus Pharmaceuticl's trailing twelve months (TTM) return on investment (ROI) is -186.43%.

Did Aeolus Pharmaceuticl gain or lose cash last quarter?

In the latest quarter, Aeolus Pharmaceuticl's net change in cash was -0.58 million.

What were Aeolus Pharmaceuticl's total assets and liabilities in the latest quarter?

As of the latest quarter, Aeolus Pharmaceuticl reported total assets of 0.79 million and total liabilities of 0.59 million.

How has Aeolus Pharmaceuticl's total revenue grown this year?

Aeolus Pharmaceuticl's total revenue was 0.13 in the previous quarter and 0.01 in the latest quarter.

What was Aeolus Pharmaceuticl's revenue per share for the latest quarter?

Aeolus Pharmaceuticl's revenue per share for the latest quarter was 3.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.